BASL logo

September 28 2023

State of the art: Predicting response to immunotherapy in liver cancer. PhD Defence Sarah Cappuyns

Program

2 - 4 pm
State-of-the-art lectures

4 - 4:30 pm
Coffee break

4:30 - 6:30 pm
PhD Defence Sarah Cappuyns

6:30 - 8:30 pm
Reception

Other non-BASL activities

Liver disease in Europe. Tackling it and reducing the harms

Liver disease in Europe

BASL - Belgian Association for the Study of the Liver
Leuvensesteenweg 643
1930 Nossegem
basl(at)basl.be